Could GLP-1 drugs help your mental health? New study finds a link
Semaglutide, the active ingredient in GLP-1 drugs, was associated with a lower risk of worsening mental health, a study published in Lancet Psychiatry found.
#Health #GLP1 #Ozempic #semglutide
https://globalnews.ca/news/11739505/glp1-anxiety-depression-mental-health-study/
Could GLP-1 drugs help your mental health? New study finds a link
Semaglutide, the active ingredient in GLP-1 drugs, was associated with a lower risk of worsening mental health, a study published in Lancet Psychiatry found.
#Health #GLP1 #Ozempic #semglutide
https://globalnews.ca/news/11739505/glp1-anxiety-depression-mental-health-study/
Could GLP-1 drugs help your mental health? New study finds a link
Semaglutide, the active ingredient in GLP-1 drugs, was associated with a lower risk of worsening mental health, a study published in Lancet Psychiatry found.
#Health #GLP1 #Ozempic #semglutide
https://globalnews.ca/news/11739505/glp1-anxiety-depression-mental-health-study/
Ceny zcela jistě půjdou dolů. Možná až na řádově stovky měsíčně místo tisícovek. Těch 15$ byl bral s velkou rezervou. A hlavně to nebude tady v Evropě.

RE: https://libera.site/item/8f834e70-9f00-5914-8556-3c9dd0573cb3

#Semaglutide
Samsung Bioepis and EpisNexLab partner with G2GBio to develop long-acting obesity treatments using microsphere-based drug delivery technology, while Samsung Epis Holdings invests 20 billion won in convertible bonds as part of open innovation strategy to expand into comprehensive bio company.
#YonhapInfomax #SamsungBioepis #ObesityTreatment #G2GBio #DrugDeliveryTechnology #Semaglutide #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=110037
Samsung Bioepis, EpisNexLab Partner with G2GBio to Develop Obesity Treatment

Samsung Bioepis and EpisNexLab partner with G2GBio to develop long-acting obesity treatments using microsphere-based drug delivery technology, while Samsung Epis Holdings invests 20 billion won in convertible bonds as part of open innovation strategy to expand into comprehensive bio company.

Yonhap Infomax
Canadian company seeks to stand out with domestically-made generic Ozempic
As geopolitical uncertainties persist, the possibility of a Canadian-made version of one of the most popular drugs in the world is prompting conversations about drug manufacturing capabilities in this country.
https://www.cbc.ca/news/canada/edmonton/canada-semaglutide-company-9.7118154?cmp=rss

💉 GLP-1 Agonists - Feb 2026

• GLP-1RAs reduce heart failure risk vs DPP-4 inhibitors
• GLP-1RAs linked to optic neuropathy risk in younger patients
• Semaglutide shows chondroprotective effects in osteoarthritis
• Tirzepatide cuts major cardiovascular events vs placebo
• Income barriers affect semaglutide prescription uptake
• Semaglutide improves post-ablation outcomes in atrial fibrillation

https://pir.sh/rk915rQdnp

#GLP1 #Diabetes #Semaglutide

Glp 1 Agonists Research Summary February 2026 - Summarized Science

Summary of key Glp 1 Agonists publications highlighting major findings, clinical relevance, and emerging research trends.

💉 GLP-1RAs are now famous for their weight loss capabilities, but a new review suggests that the rebound weight people gain after stopping the medication is real, though you might not regain all of the weight back

https://www.scimex.org/newsfeed/rebound-weight-after-stopping-ozempic-like-drugs-is-real-but-you-might-not-regain-all-the-weight

#science #sciencenews #research #stem #facts #knowledge #sciencefacts #GLP1 #ozempic #wegovy #semaglutide #tirzepatide

💉 An international team of researchers say #GLP-1 RAs - the type of diabetes/weight loss drugs that include #Ozempic and #Wegovy - are more effective in women than men

https://www.scimex.org/newsfeed/ozempic-like-drugs-work-best-in-women

#science #sciencenews #research #stem #facts #knowledge #sciencefacts #semaglutide